ICCBBA is an active participant in the HL7 FHIR Orders and Observations Healthcare Product group impacting the enhanced BiologicallyDerivedProduct resource.
As part of our ongoing efforts to enhance traceability and biovigilance for all medical products of human origin, ICCBBA is pleased to have made significant contributions to the enhanced BiologicallyDerivedProduct resource in HL7 FHIR R5!
For more information, please click here!
Comments